Related Experiment Video
Updated: Jun 22, 2026

12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.0K
Computational Screening to Predict MicroRNA Targets in the Flavivirus 3' UTR Genome: An Approach for Antiviral
Rodolfo Gamaliel Avila-Bonilla1, Juan Santiago Salas-Benito2
1Laboratorio de Genómica y Biología Molecular de ARNs, Departamento de Genética y Biología Molecular, Cinvestav, Av. IPN 2508, Mexico City 07360, Mexico.
International Journal of Molecular Sciences
|September 28, 2024
Summary
Researchers identified specific microRNAs (miRNAs) in humans and mosquitoes that can bind to the 3' untranslated region (3' UTR) of flaviviruses. These findings suggest potential new antiviral strategies against flavivirus infections.
Area of Science:
- Molecular Biology
- Virology
- Bioinformatics
Background:
- MicroRNAs (miRNAs) regulate gene expression by targeting messenger RNA (mRNA).
- Host miRNAs can impact flavivirus replication by altering host gene expression or directly interacting with the viral genome.
- The conserved 3' untranslated region (3' UTR) of flaviviruses is a key target for host-derived miRNAs.
Purpose of the Study:
- To computationally identify human and mosquito microRNAs that potentially bind to the flavivirus 3' UTR.
- To explore the potential of these identified miRNAs as novel antiviral agents against flavivirus infections.
Main Methods:
- Utilized bioinformatic tools to analyze potential interactions between miRNAs and the flavivirus 3' UTR.
- Screened for miRNAs from human and mosquito species capable of binding to the conserved viral genomic region.
Main Results:
- Identified two human miRNAs (miR-6842, miR-661) that may target the flavivirus 3' UTR.
- Discovered five mosquito miRNAs (miR-9-C, miR-2945-5p, miR-11924, miR-282-5p, miR-79) with potential binding sites on the flavivirus 3' UTR.
- These findings highlight specific miRNA candidates for further investigation.
Conclusions:
- The study computationally identified novel human and mosquito miRNAs targeting the flavivirus 3' UTR.
- These miRNAs represent promising candidates for developing new antiviral therapies against flavivirus diseases.
- Further experimental validation is warranted to confirm these interactions and their therapeutic potential.

